GABA(A) Receptor-Associated Protein Like 1 (GABARAPL1) (N-Term) Peptid
GABARAPL1
Reaktivität: Human
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle GABARAPL1 Produkte
- GABARAPL1 (GABA(A) Receptor-Associated Protein Like 1 (GABARAPL1))
- Protein Region
- N-Term
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-GABARAPL1 antibody (Catalog #: ARP55398_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- GABARAPL1 (GABA(A) Receptor-Associated Protein Like 1 (GABARAPL1))
- Hintergrund
-
GABARAPL1 increases cell-surface expression of kappa-type opioid receptor through facilitating anterograde intracellular trafficking of the receptor.
Alias Symbols: APG8L, ATG8, ATG8L, GEC1, ATG8B, APG8-LIKE
Protein Interaction Partner: CALCOCO2,OPRK1,SQSTM1,VDR,CALCOCO2,SQSTM1
Protein Size: 117 - Molekulargewicht
- 14 kDa
- Gen-ID
- 23710
- NCBI Accession
- NM_031412, NP_113600
- UniProt
- Q9H0R8
-
Sie sind hier:
